中文名 | 4-氯-1,5-萘啶 |
---|---|
英文名 | 4-Chloro-1,5-naphthyridine |
英文别名 |
4-chloro-[1,5]naphthyridine
1,5-Naphthyridine, 4-chloro- 4-chloranyl-1,5-naphthyridine 4-Chloro-1,5-naphthyridine 4-Chlor-1,5-naphtyridin 8-chloro-1,5-naphthyridine 4-Chlor-1,5-naphthyridin |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 269.2±20.0 °C at 760 mmHg |
熔点 | 102-103ºC |
分子式 | C8H5ClN2 |
分子量 | 164.592 |
闪点 | 142.5±7.4 °C |
精确质量 | 164.014130 |
PSA | 25.78000 |
LogP | 0.89 |
外观性状 | 类白色到浅黄色固体 |
蒸汽压 | 0.0±0.5 mmHg at 25°C |
折射率 | 1.663 |
储存条件 | 2-8°C |
危害码 (欧洲) | Xi |
---|---|
海关编码 | 2933990090 |
~61% 7689-63-6 |
文献:Sieb, David; Schuhen, Katrin; Morgen, Michael; Herrmann, Heike; Wadepohl, Hubert; Lucas, Nigel T.; Baker, Robert W.; Enders, Markus Organometallics, 2012 , vol. 31, # 1 p. 356 - 364 |
~40% 7689-63-6 |
文献:Nishimura, Nobuko; Siegmund, Aaron; Liu, Longbin; Yang, Kevin; Bryan, Marian C.; Andrews, Kristin L.; Bo, Yunxin; Booker, Shon K.; Caenepeel, Sean; Freeman, Daniel; Liao, Hongyu; McCarter, John; Mullady, Erin L.; San Miguel, Tisha; Subramanian, Raju; Tamayo, Nuria; Wang, Ling; Whittington, Douglas A.; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.; Norman, Mark H. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4735 - 4751 |
~% 7689-63-6 |
文献:Adams et al. Journal of the American Chemical Society, 1946 , vol. 68, p. 1317 |
~36% 7689-63-6 |
文献:VIFOR (INTERNATIONAL) AG Patent: US2012/214803 A1, 2012 ; Location in patent: Page/Page column 174 ; US 20120214803 A1 |
~% 7689-63-6 |
文献:VIFOR (INTERNATIONAL) AG Patent: US2012/214803 A1, 2012 ; US 20120214803 A1 |
~% 7689-63-6 |
文献:Nishimura, Nobuko; Siegmund, Aaron; Liu, Longbin; Yang, Kevin; Bryan, Marian C.; Andrews, Kristin L.; Bo, Yunxin; Booker, Shon K.; Caenepeel, Sean; Freeman, Daniel; Liao, Hongyu; McCarter, John; Mullady, Erin L.; San Miguel, Tisha; Subramanian, Raju; Tamayo, Nuria; Wang, Ling; Whittington, Douglas A.; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.; Norman, Mark H. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4735 - 4751 |
~% 7689-63-6 |
文献:INFINITY PHARMACEUTICALS INC.; INTELLIKINE, LLC; CASTRO, Alfredo, C.; EVANS, Catherine, A.; JANARDANANNAIR, Somarajannair; LESCARBEAU, Andre; LIU, Tao; SNYDER, Daniel, A.; TREMBLAY, Martin, R.; REN, Pingda; LIU, Yi; LI, Liansheng; CHAN, Katrina Patent: WO2013/12915 A1, 2013 ; WO 2013/012915 A1 |
~% 7689-63-6 |
文献:INFINITY PHARMACEUTICALS INC.; INTELLIKINE, LLC; CASTRO, Alfredo, C.; EVANS, Catherine, A.; JANARDANANNAIR, Somarajannair; LESCARBEAU, Andre; LIU, Tao; SNYDER, Daniel, A.; TREMBLAY, Martin, R.; REN, Pingda; LIU, Yi; LI, Liansheng; CHAN, Katrina Patent: WO2013/12915 A1, 2013 ; WO 2013/012915 A1 |
上游产品 5 | |
---|---|
下游产品 3 | |
海关编码 | 2933990090 |
---|---|
中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |